Literature DB >> 5260739

Studies with heterologous antilymphocytic serum as a therapy for chronic lymphocytic leukemia.

A D Tsirimbas, H Pfisterer, B Hornung, S Thierfelder, G Michlmayr, W Stich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5260739     DOI： 10.1007/bf01637327

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  3 in total

1.  INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. III. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKAEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.

Authors:  J LIBANSKY
Journal:  Neoplasma       Date:  1963       Impact factor: 2.575

2.  [Lymphopenia caused by antilymphocyte serum in chronic lymphatic leukemia].

Authors:  H Pfisterer; G Michlmayr; E Meinzel; H Bolland; A D Tsirimbas; B Hornung; W Ruppelt; W Stich
Journal:  Dtsch Med Wochenschr       Date:  1968-11-08       Impact factor: 0.628

3.  [Preparation and effect of heterologous anti-dog lymphocyte serums].

Authors:  R Pichlmayr
Journal:  Z Gesamte Exp Med       Date:  1967
  3 in total
  1 in total

1.  Specificity of rabbit antisera against mouse leukaemias in vitro.

Authors:  A E Reif; C A Kim
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.